Matthew Boland, PHD | |
245 Mount Rose St, Reno, NV 89509-3355 | |
(775) 448-6828 | |
Not Available |
Full Name | Matthew Boland |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 8 Years |
Location | 245 Mount Rose St, Reno, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013342831 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PY0852 (Nevada) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Health Psychology Associates Llc | 6204180284 | 8 |
News Archive
Accera, Inc. will launch Axona in the United States for Alzheimer's disease (AD) in the first quarter of 2009.
The Obama administration also gave conditional approval on Monday to six states - all led by Democratic governors - that were the first to meet the health law's rules for setting up health insurance marketplaces.
Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers has the potential to avert approximately 12,000 lung cancer deaths each year in the United States.
Revolution in Libya. Revolution in Egypt. Revolution in Tunisia. The Middle East and North Africa face unprecedented change as dictatorships crumble and people clamor for democracy.
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
› Verified 7 days ago
Entity Name | Health Psychology Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366836702 PECOS PAC ID: 6204180284 Enrollment ID: O20181109000990 |
News Archive
Accera, Inc. will launch Axona in the United States for Alzheimer's disease (AD) in the first quarter of 2009.
The Obama administration also gave conditional approval on Monday to six states - all led by Democratic governors - that were the first to meet the health law's rules for setting up health insurance marketplaces.
Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers has the potential to avert approximately 12,000 lung cancer deaths each year in the United States.
Revolution in Libya. Revolution in Egypt. Revolution in Tunisia. The Middle East and North Africa face unprecedented change as dictatorships crumble and people clamor for democracy.
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Boland, PHD 245 Mount Rose St, Reno, NV 89509-3355 Ph: (775) 448-6828 | Matthew Boland, PHD 245 Mount Rose St, Reno, NV 89509-3355 Ph: (775) 448-6828 |
News Archive
Accera, Inc. will launch Axona in the United States for Alzheimer's disease (AD) in the first quarter of 2009.
The Obama administration also gave conditional approval on Monday to six states - all led by Democratic governors - that were the first to meet the health law's rules for setting up health insurance marketplaces.
Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers has the potential to avert approximately 12,000 lung cancer deaths each year in the United States.
Revolution in Libya. Revolution in Egypt. Revolution in Tunisia. The Middle East and North Africa face unprecedented change as dictatorships crumble and people clamor for democracy.
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
› Verified 7 days ago
Dr. Samantha Lynn Schilling, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Va Sierra Nevada Health Care System, 975 Kirman Ave, Reno, NV 89502 Phone: 775-326-2921 | |
Cyndy Guadalupe Soto-lopez, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1664 N Virginia St, Reno, NV 89557 Phone: 775-682-6520 | |
Dr. Ethan Emery Steever, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5865 Tyrone Rd, Suite 103, Reno, NV 89502 Phone: 775-786-2828 Fax: 775-786-3877 | |
Dr. Davena Limitless Longshore, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4781 Caughlin Pkwy, Reno, NV 89519 Phone: 775-826-3311 | |
Dr. Jennifer Ann Luboski, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1325 Airmotive Way Ste 175e, Reno, NV 89502 Phone: 775-525-3007 | |
Dr. Tristan Sophia, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 1881 S Arlington 201, Reno, NV 89509 Phone: 406-426-8168 Fax: 406-723-5406 |